Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis (Q36206282)

12 August 2017

Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis (English)

1 reference

12 August 2017

0 references

0 references

6

Alberto Ascherio

1 reference

12 August 2017

2

Eilis J O'Reilly

1 reference

12 August 2017

3

Kassandra L Munger

1 reference

12 August 2017

1

Kelly Claire Simon

1 reference

12 August 2017

Susan Finerty

4

1 reference

PMCID

3433051

12 August 2017

Andrew J Morgan

series ordinal

5

1 reference

PMCID

3433051

12 August 2017

language of work or name

1 reference

30 January 2012

1 reference

Multiple Sclerosis Journal

12 August 2017

1 reference

12 August 2017

18

1 reference

12 August 2017

8

1 reference

12 August 2017

1185-1187

1 reference

Primary infection with the Epstein-Barr virus and risk of multiple sclerosis

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433051

Epstein-Barr virus neutralizing and early antigen antibodies in multiple sclerosis

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433051

Epstein-barr virus infection and multiple sclerosis: a review

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433051

Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433051

Environmental risk factors for multiple sclerosis. Part I: The role of infection

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433051

Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433051

Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433051

Indirect measurement of Epstein-Barr virus neutralising antibodies by ELISA.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3433051

22 September 2018

Identifiers

DOI

10.1177/1352458511433920

1 reference

12 August 2017

1 reference

12 August 2017

1 reference

PMCID

3433051